Table 4

Results of the mental health dimension of the SF-36v2 in 16 evaluable subjects

Study groups and time points
SF-36v2 scores, mean (SD)



Vitality
Social functioning
Role-emotional
Mental health

Hyal-Joint® (n = 8)




     Baseline
49.4 (9.9)
38.4 (10.1)
36.9 (10.9)
42.3 (18.8)
     Week 4
50.9 (4.4)
46.6 (8.5)
44.2 (5.5)
49.7 (13.3)
     Week 8
52.1 (4.7)
43.2 (12.4)
42.3 (10.2)
44.4 (16.3)
     Change baseline vs week 4
1.6 (9.9)
8.2 (8.8)
7.3 (7.3)
7.4 (12.2)
          P value
0.669
0.033
0.026
0.131
     Change baseline vs week 8
2.7 (11.9)
4.8 (12.5)
5.4 (8.8)
2.1 (15.2)
          P value
0.537
0.318
0.129
0.707
Placebo (n = 8)




     Baseline
49.8 (12.3)
44.6 (11.6)
39.4 (13.4)
48.3 (9.9)
     Week 4
49.4 (9.1)
49.3 (8.2)
38.9 (11.6)
49.7 (10.9)
     Week 8
53.3 (6.5)
46.6 (8.9)
44.7 (9.6)
52.5 (8.4)
     Change baseline vs week 4
-0.4 (8.4)
4.8 (4.5)
-0.5 (7.0)
1.4 (9.4)
          P value
0.897
0.021
0.843
0.684
     Change baseline vs week 8
3.5 (9.3)
2.0 (7.7
5.3 (6.2)
4.2 (9.7)
          P value
0.323
0.477
0.045
0.258

Kalman et al. Nutrition Journal 2008 7:3   doi:10.1186/1475-2891-7-3

Open Data